Assessment of Intracerebral Hematoma

The study will assess acute intracerebral hematoma expansion within the first 48 hours from the onset using transcranial duplex sonography in patients who have acute intracerebral hematoma , and will ...

Lead sponsor: Assiut University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

waleed Gafar

CONTACT

00201012110708 waleed.gafar1995@gmail.com

Related studies

RECRUITINGNA

Sonography-guided Resection of Brain Mass Lesions

NCT05484245 · Tumor, Brain, Arteriovenous Malformations, and more

WITHDRAWNNA

Stereotactic, Robot-assisted Intracerebral Hemorrhage Clot Evacuation

NCT03414307 · Intracerebral Hematoma

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 15, 2021Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment120

Start dateJan 2022

Last updatedDec 15, 2021

Condition

Intracerebral Hematoma

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 15, 2021Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions